🔗 Share this article Prestigious Prize Honors Groundbreaking Body's Defenses Discoveries The Nobel Prize in Physiology or Medicine has been granted for revolutionary discoveries that clarify how the immune system targets dangerous pathogens while protecting the body's own cells. A trio of esteemed researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this honor. The work uncovered specialized "sentinels" within the defense system that eliminate malfunctioning immune cells that could harming the body. The findings are now paving the way for new therapies for autoimmune diseases and cancer. The laureates will divide a prize fund worth 11m SEK. Crucial Findings "Their work has been essential for understanding how the body's defenses functions and the reason we don't all develop serious self-attack conditions," stated the chair of the award panel. This team's studies address a fundamental question: In what way does the defense system protect us from countless invaders while keeping our healthy cells unharmed? The body's protection system uses white blood cells that scan for indicators of disease, even viruses and germs it has not met before. Such defenders employ detectors—called receptors—that are generated randomly in a vast number of variations. This provides the defense network the capacity to fight a wide array of invaders, but the unpredictability of the process inevitably produces white blood cells that can attack the body. Protectors of the Body Scientists previously understood that some of these problematic defense cells were eliminated in the immune organ—where immune cells develop. This year's Nobel Prize honors the identification of T-reg cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize any immune cells that attack the healthy cells. It is known that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis. A Nobel panel added, "The discoveries have established a novel area of research and accelerated the development of new therapies, for instance for tumors and autoimmune diseases." Regarding malignancies, T-regs block the system from attacking the growth, so research are focused on reducing their numbers. In autoimmune diseases, trials are testing boosting T-reg cells so the organism is no longer being harmed. A comparable method could also be effective in reducing the chances of transplanted organ failure. Pioneering Studies Prof Sakaguchi, of a Japanese institution, performed tests on mice that had their immune gland extracted, causing autoimmune disease. He showed that introducing immune cells from healthy animals could stop the illness—suggesting there was a system for blocking defenders from harming the body. Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in rodents and humans that led to the identification of a gene critical for how T-regs function. "The groundbreaking work has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally targeting the healthy cells," said a prominent biological science specialist. "The work is a striking illustration of how fundamental biological research can have broad implications for public health."